2052 related articles for article (PubMed ID: 30414862)
21. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.
Hu H; Qiu Y; Guo M; Huang Y; Fang L; Peng Z; Ji W; Xu Y; Shen S; Yan Y; Huang X; Zheng J; Su C
Oncotarget; 2015 Jan; 6(2):1079-89. PubMed ID: 25473902
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma.
Liu Y; Chen X; Luo W; Zhao Y; Nashan B; Huang L; Yuan X
Cancer Med; 2023 Aug; 12(15):16370-16385. PubMed ID: 37326143
[TBL] [Abstract][Full Text] [Related]
23. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Wang L; Hu D; Xie B; Xie L
Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
[TBL] [Abstract][Full Text] [Related]
24. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.
Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR
J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
[TBL] [Abstract][Full Text] [Related]
26. Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma.
Meng G; Li B; Chen A; Zheng M; Xu T; Zhang H; Dong J; Wu J; Yu D; Wei J
Br J Cancer; 2020 Jan; 122(1):111-120. PubMed ID: 31819179
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic reticulum stress induced LOX-1
Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model.
Hu Y; Liu J; Cui P; Liu T; Piao C; Xu X; Zhang Q; Xiao M; Lu Y; Liu X; Wang Y; Lu X
Cell Immunol; 2020 Feb; 348():104036. PubMed ID: 31924315
[TBL] [Abstract][Full Text] [Related]
29. IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment.
Mei Y; Zhu Y; Yong KSM; Hanafi ZB; Gong H; Liu Y; Teo HY; Hussain M; Song Y; Chen Q; Liu H
Cell Rep; 2024 Mar; 43(3):113835. PubMed ID: 38412100
[TBL] [Abstract][Full Text] [Related]
30. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
Wang K; Wu J; Yang Z; Zheng B; Shen S; Wang RR; Zhang Y; Wang HY; Chen L; Qiu X
Cancer Lett; 2024 Apr; 586():216690. PubMed ID: 38307410
[TBL] [Abstract][Full Text] [Related]
31. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
32. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
Hsieh CC; Hung CH; Chiang M; Tsai YC; He JT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614930
[TBL] [Abstract][Full Text] [Related]
33. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
34. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
35. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
36. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
[TBL] [Abstract][Full Text] [Related]
37. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma.
Yang CK; Huang CH; Hu CH; Fang JH; Chen TC; Lin YC; Lin CY
PLoS One; 2023; 18(1):e0280023. PubMed ID: 36598909
[TBL] [Abstract][Full Text] [Related]
39. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.
Wang Z; Liu Y; Zhang Y; Shang Y; Gao Q
Oncotarget; 2016 Jan; 7(4):4760-9. PubMed ID: 26716894
[TBL] [Abstract][Full Text] [Related]
40. The Combined Antitumor Effects of
Zhang J; Wu N; Lian Z; Feng H; Jiang Q; Chen X; Gong J; Qiao Z
Technol Cancer Res Treat; 2017 Dec; 16(6):1083-1091. PubMed ID: 29332456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]